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Vascular Endothelial Cell Adherens Junction
Assembly and Morphogenesis Induced
by Sphingosine-1-Phosphate
dimensional collagen or fibrin gels with phorbol 12-myris-
tic 13-acetate (PMA) results in the formation of networks
of capillary-like structures (Montesano and Orci, 1985).
Angiogenic factors such as VEGF and FGF induce endo-
thelial cell migration, mitogenesis, and survival (Friesel
Menq-Jer Lee, Shobha Thangada, Kevin P. Claffey,
Nicolas Ancellin, Catherine H. Liu, Michael Kluk,
Mario Volpi, Ramadan I. Sha'afi, and Timothy Hla*
Center for Vascular Biology
Department of Physiology
and Maciag, 1995; Ilan et al., 1998; Satake et al., 1998).University of Connecticut Health Center
In addition, VEGF is a potent inducer of vascular perme-Farmington, Connecticut 06030-3501
ability, a prerequisite initial event for plasma exudation
and fibrin clot formation, a matrix permissive for angio-
genesis (Iruela-Arispe and Dvorak, 1997). However, fac-Summary
tors and mechanisms that regulate morphogenesis of
endothelial cells into capillary-like networks are poorlyVascular endothelial cells undergo morphogenesis
understood.into capillary networks in response to angiogenic fac-
The EDG-1 (Endothelial Differentiation Gene-1) gene,tors. We show here that sphingosine-1-phosphate
which encodes a G protein±coupled receptor (GPCR),(SPP), a platelet-derived bioactive lipid, activates the
is rapidly induced by PMA in human umbilical vein endo-EDG-1 and -3 subtypes of G protein±coupled receptors
thelial cells (HUVEC) (Hla and Maciag, 1990). Severalon endothelial cells to regulate angiogenesis. SPP in-
other GPCRs related in primary sequence to EDG-1 wereduces the Gi/mitogen-activated protein kinase/cell isolated from different laboratories, including EDG-2/survival pathway and the small GTPase Rho- and Rac-
VZG-1 (Hecht et al., 1996), EDG-3 (Yamaguchi et al.,
coupled adherens junction assembly. Both EDG-1-
1996), EDG-4 (An et al., 1998), and EDG-5 (Okazaki et
and EDG-3-regulated signaling pathways are required
al., 1993). EDG-1, EDG-3, and EDG-5 are high-affinity
for endothelial cell morphogenesis into capillary-like
receptors for the platelet-derived bioactive lipid sphin-
networks. Indeed, SPP synergized with polypeptide
gosine-1-phosphate (SPP) (Yatomi et al., 1997; Lee et
angiogenic growth factors in the formation of mature al., 1998; Ancellin and Hla, 1999), whereas EDG-2 and
neovessels in vivo. These data define SPP as a novel EDG-4 are lysophosphatidic acid (LPA) receptors (Hecht
regulator of angiogenesis. et al., 1996; An et al., 1998). The EDG-1 family of recep-
tors are developmentally regulated and differ in tissue
distribution (Hecht et al., 1996; Liu and Hla, 1997). Also,
Introduction EDG-1 couples to Gi (Lee et al., 1996) but not the Gq
protein; whereas EDG-3 potently activated Gq and G13
Angiogenesis, the process of new blood vessel forma- polypeptides (Ancellin and Hla, 1999; Windh et al., 1999).
tion, is important in embryonic development as well as EDG-5 also couples to Gq, albeit less effectively than
physiological events. Dysregulated angiogenesis is in- EDG-3, although it is capable of activating G13 (Ancellin
volved in various pathological conditions, for example, and Hla, 1999; Windh et al., 1999). Thus, EDG-1, -3, and
solid tumor growth, rheumatoid arthritis, and diabetic -5 are SPP receptor subtypes that couple to different
retinopathy (Folkman, 1995). Angiogenesis is initiated signaling pathways.
by vascular endothelial cells and involves their orderly SPP is synthesized intracellularly by the sequential
proliferation, migration, and morphogenesis into new actions of sphingomyelinase, ceramidase, and sphingo-
capillary networks. Such events are precisely regulated sine kinase (Spiegel and Merril, 1996). SPP, like its
by soluble growth factors as well as extracellular matrix± structural relative LPA, is responsible for much of the
derived signals (Folkman, 1995; Bader et al., 1998; Eli- lipid-derived biological activities of serumÐsuch as
proliferation, survival, stress fiber and focal adhesionceiri and Cheresh, 1999). The balance between positive
plaque formation, fibronectin matrix assembly, cell(angiogenic) and negative (anti-angiogenic) factors in
rounding, and cell migration (reviewed in Hla et al., 1999).vivo may be important for the control of angiogenesis
Controversy exists as to whether SPP acts as an extra-(Iruela-Arispe and Dvorak, 1997; O'Reilly et al., 1997).
cellular mediator or an intracellular second messengerFolkman and Haudenschild showed that stimulation
(Hla et al., 1999). Although these roles need not be mutu-of isolated endothelial cells with tumor-conditioned me-
ally exclusive, it is important to define precisely whichdium induces the formation of capillary-like networks
receptor/effector pathway is important for specific bio-(Folkman and Haudenschild, 1980). These early studies
logical actions of SPP.suggested that the endothelial cells are capable of ex-
In this study, we describe a novel extracellular func-pressing the genetic machinery required to form a capil-
tion of SPP as an angiogenic modulator.lary network when appropriately stimulated. Thus, cul-
tured endothelial cells have become a widely used
Resultsmodel system to elucidate the mechanisms of angiogen-
esis. Treatment of endothelial cells grown on three-
EDG-1 and -3 Are Functional SPP Receptor Subtypes
in Endothelial Cells
Northern blot analysis of HUVEC poly(A)1 RNA showed* To whom correspondence should be addressed (e-mail: hla@
sun.uchc.edu). that EDG-1 was abundantly expressed, the EDG-3 tran-
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As shown in Figure 1C, SPP (10±500 nM) activated ERK
activity in a dose-dependent manner in HUVEC. This
response was inhibited completely by pretreating cells
with pertussis toxin and PD98059, indicating that this
activity is dependent on the Gi protein and MAP kinase
kinase. Complete inhibition by pertussis toxin suggests
that most of the SPP effects on MAP kinase are medi-
ated by EDG-1.
Regulation of Adherens Junction Assembly
by SPP
Treatment of endothelial cells with SPP for 30 min re-
sulted in dramatic increase in actin stress fibers and
cortical actin structures in endothelial cells (see Supple-
mental Data below). These effects are mediated by the
plasma membrane receptors because intracellular mi-
croinjection of SPP induced neither stress fibers nor
cortical actin (see Supplemental Data).
The formation of stress fibers and cortical actin in 3T3
fibroblasts is dependent on the activity of Rho and Rac
small GTPases, respectively (Ridley et al., 1992; Hall,
1998). Intracellular microinjection of the C3 exoenzyme,
a specific inhibitor of Rho abolished the SPP-induced
stress fibers but not the cortical actin. Microinjection
of dominant-negative Rac protein (N17Rac) completely
inhibited the formation of both stress fibers and cortical
actin. Pertussis toxin did not inhibit either of the actin
changes in endothelial cells (see Supplemental Data).
These data suggest that the extracellular action of SPP
via a non-Gi-dependent pathway transduces signals
through the Rac and Rho small GTPases to regulate the
cytoskeletal architecture of endothelial cells. Further-Figure 1. Expression of EDG-1 and EDG-3 in Endothelial Cells
more, similar to the findings in fibroblasts (Ridley et al.,(A) Poly(A)1 RNA from HUVEC (lane 1) and HEK293 (lane 2) were
1992; Hall, 1998), Rac appears to act upstream of Rhoprobed with EDG-1, -3, -5, or GAPDH cDNAs. Positive control (lane
3), in vitro transcripts for EDG-1, -3, and -5. in the induction of endothelial cell cytoskeletal changes.
(B) SPP-induced intracellular calcium. HUVEC were loaded with We showed previously that SPP induces morphoge-
Indo-1, stimulated with different doses of SPP, and Ca21 (in nM) netic differentiation and upregulates P-cadherin-based
was quantitated. Some cells were pretreated with PTx (500 ng/ml) adherens junctions in EDG-1-transfected HEK293 cells
for 16 hr. D[Ca21] represents the difference in intracellular free Ca21.
(Lee et al., 1998). Thus, we investigated the effect of(C) SPP induces Gi-dependent MAP kinase activation. Endothelial
SPP on cell±cell junctions in endothelial cells. Whencells were stimulated with SPP for 10 min and ERK-2 kinase activity
was measured by an immune complex kinase assay as described. HUVEC were treated with SPP, VE-cadherin, a-, b-, and
Some cells were pretreated with PTx (200 ng/ml) or PD98059 (10 g-catenin localization at cell±cell junctions was dramati-
mM) for 2 hr prior to stimulation. cally increased within 1 hr (Figure 2A and data not
shown). Confocal immunofluorescence microscopy in-
dicates that SPP treatment increased the localization
of VE-cadherin (Figures 2A and 3C) into discontinuousscript was expressed at a much lower level and the EDG-5
mRNA was undetectable (Figure 1A). EDG-1 expression structures at cell±cell contact regions, suggesting that
SPP induces the formation of adherens junctions. Treat-was estimated to be 16-fold more abundant than EDG-3.
In contrast, EDG-3 is the predominant SPP receptor iso- ment with related lipids (sphingosine, sphingomyelin,
ceramide, ceramide-1-phosphate) that do not interacttype in human embryonic kidney (HEK)293 cells.
We next tested, by sensitive functional assays, the with SPP receptors had no effect (data not shown). Also,
direct microinjection of SPP (ranging from 500 nM topresence of Gi- and Gq-coupled SPP receptors in HU-
VEC. As shown in Figure 1B, SPP induced a robust 500 mM) into the cytoplasm did not increase the immu-
noreactivity of VE-cadherin and catenins at cell±cellcalcium response in endothelial cells, which was inhib-
ited approximately 90% by pertussis toxin, whereas the junctions (see Supplemental Data).
Formation of mature adherens junctions requires ho-Gq-coupled ATP receptor response was not pertussis
toxin sensitive. These data suggest that EDG-1, a mophilic binding of intercellular cadherins, association
with cytoplasmic polypeptides, and attachment to theGi-coupled SPP receptor, is responsible for the majority of
SPP-induced calcium responses in HUVEC. The pertus- cytoskeleton, which ultimately results in the partitioning
of cadherin molecules into the detergent-insoluble frac-sis toxin±resistant component may be due to the activity
of EDG-3. Secondly, we utilized the SPP-induced extra- tion (Yap et al., 1997). Fractionation of HUVEC cell
lysates showed that SPP-induced, in a dose- andcellular signal±activated kinase (ERK) activation assay.
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in a mutually exclusive manner in adherens junctional
complexes.
Requirement for Rac and Rho GTPases in SPP-
Induced Adherens Junction Assembly
Next, we examined the subcellular localization of Rac
and Rho in HUVEC before and after SPP treatment.
Interestingly, treatment with SPP for 10±30 min resulted
in significant redistribution of Rac to the cell±cell contact
areas, whereas subcellular localization of Rho was not
altered (Figure 3A). Tiam1, a guanine nucleotide ex-
change factor specific for Rac (Michiels et al., 1995),
was also translocated to cell±cell contact areas (Figure
3A). Double immunostaining exhibited an overlapping
pattern between Tiam1 and b-catenin after SPP treatment.
To determine if Rho and Rac small GTPases are re-
quired for SPP-induced adherens junction assembly, C3
exoenzyme and dominant-negative N17Rac polypep-
tide were microinjected into HUVEC cells. As shown in
Figures 3B and 3C, microinjection of C3 and N17Rac
dramatically diminished SPP-induced VE-cadherin im-
munoreactivity at cell±cell junctions. Similar results were
observed for b-catenin immunoreactivity (see Supple-
mental Data). Neither the injection of FITC-mouse IgG
nor the inactivation of the heterotrimeric Gi protein by
treatment or microinjection of pertussis toxin inhibited
VE-cadherin and b-catenin localization at cell±cell junc-Figure 2. SPP Induces Adherens Junction Assembly in Endothelial
Cells tions (data not shown). These data suggest that SPP-
(A) Recently confluent HUVEC cells were treated with (SPP, 500 nM) induced Rho and Rac activation is required for adherens
or without (Cont.) for 1 hr, and immunofluorescence analysis of VE- junction assembly in HUVEC.
cadherin and b-catenin was done. Data are representative of at
least six experiments. Scale bar 5 13.4 mm.
Requirement for EDG-1 and EDG-3 in SPP-Induced(B) SPP induces Triton-X-100 insolubility of VE-cadherin. Unstimu-
Cytoskeletal Changes and Adherenslated HUVEC cells (2) or cells stimulated with 500 nM of SPP for 1
Junction Assemblyhr (1) were sequentially fractionated with Triton X-100 (0.05%, 0.1%,
0.5%). The insoluble lysates were further extracted with 1% Triton We next determined the involvement of the EDG-1 and -3
X-100 plus 1% SDS (SDS) at 958C for 10 min. Equal amounts of subtypes of SPP receptors in the assembly of adherens
protein extracts were probed with anti-VE-cadherin antibody (upper junctions. For this, antisense phosphothioate oligonu-
panel). (Middle panel) HUVEC cells were stimulated with 500 nM of
cleotides (PTO), which are designed to bind to the trans-SPP for indicated times, Triton X-100±insoluble pellets were pre-
lational initiation site on the mRNA and thus block thepared and probed for VE-cadherin. (Lower panel) HUVEC cells were
expression of EDG-1 and -3 receptors were developed.treated for 1 hr with indicated concentration of SPP. Triton X-100±
resistant VE-cadherin levels were determined. As shown in Figure 4A, coinjection of EDG-1 antisense
(C) SPP induces adherens junctional complexes in detergent-insolu- PTO with the EDG-1 cRNA into Xenopus oocytes re-
ble fractions. HUVEC cells were labeled with [35S]-methionine and sulted in profound inhibition of EDG-1 expression, as
treated or not with 500 nM SPP. Protein complexes in the insoluble
determined by suppression of SPP-induced calciumfractions were cross-linked by DSP and immunoprecipitated with
rises (Ancellin and Hla, 1999). EDG-3 antisense PTOrespective antibodies as described. (*), an unidentified polypeptide
did not inhibit the EDG-1 cRNA expression, indicatingwith apparent molecular mass of 80 kDa. NS, polypeptides bound
to protein A beads nonspecifically. specificity. Likewise, EDG-3 antisense PTO only inhib-
ited the respective cRNA for EDG-3. These data suggest
that the EDG-1 and -3 PTOs are specific inhibitors of
respective receptor expression. These reagents weretime-dependent manner, an increase in the amount of
VE-cadherin in the Triton X-100 insoluble fraction; how- microinjected into the cytoplasm of HUVEC to block the
expression of EDG-1 and -3 receptors, and SPP-inducedever, the overall level of protein was not altered (Figure
2B). Consistent with the immunofluorescence data, the VE-cadherin assembly into cell-cell junctions was ana-
lyzed. As shown in Figure 4B and Table 1, both EDG-1increase of VE-cadherin in Triton X-100 insoluble frac-
tions peaked at 1±2 hr following SPP treatment. and -3 antisense PTOs inhibited the SPP-induced VE-
cadherin localization at cell±cell junctions. In contrast,To directly show that SPP signaling in endothelial cells
regulates adherens junction assembly, a coimmuno- neither the complementary nor the scrambled sequence
of EDG-1 and -3 oligonucleotides inhibited VE-cadherinprecipitation experiment was conducted. As shown in
Figure 2C, SPP significantly increased the a-catenin and assembly significantly. Furthermore, antisense EDG-1
PTO attenuated the formation of cortical actin structuresVE-cadherin polypeptides in the g- and b-catenin immu-
noprecipitates. In agreement with previous findings in HUVEC, which are known to be induced by the Rac
pathway (Figure 4C). In contrast, formation of stress(Hinck et al., 1994), b-catenin and g-catenin are found
Cell
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Figure 3. SPP-Induced Adherens Junction Assembly Requires Rho and Rac Small GTPases
(A) SPP induces the translocation of Rac and Tiam1 to cell±cell contact sites. HUVEC cells were stimulated with 500 nM of SPP for 30 min,
immunostained with Rac or Rho antibodies. Scale bar, upper panels 5 8.7 mm. In the lower panels, cells were labeled with Tiam1 and b-catenin
antibodies, and then stained with FITC-goat anti-rabbit and TRITC-sheep anti-mouse antibodies, respectively. SPP induces both Tiam1 and
b-catenin translocation to cell±cell contact sites (indicated by arrowheads), but not the isolated cell edges (arrows). Scale bar, lower panels 5
7.7 mm; C., control.
(B) SPP-induced VE-cadherin translocation to cell±cell junctions requires Rho and Rac GTPases. HUVEC were microinjected with FITC-IgG
alone (first row), FITC-IgG together with C3 exoenzyme (second row), or N17Rac (third row). Following stimulation with SPP, cells were stained
with anti-VE-cadherin. Note that injection of C3 and N17Rac diminished the SPP-induced VE-cadherin immunoreactivity at cell±cell contact
areas (arrows). Scale bar 5 20 mm.
(C) confocal images of anti-VE-cadherin staining in unstimulated (left) or SPP-stimulated (middle) HUVEC. When cells were injected with FITC-
IgG plus C3 exotoxin and stained with anti-VE-cadherin, superimposed confocal image (right) shows that SPP-induced zigzag-like staining
pattern was reduced to a smooth plasma membrane staining pattern by C3 treatment (green cells). Lower inset shows the Z section of the
confocal image. Note that strong VE-cadherin staining was observed in the apical region of cell±cell junctions in uninjected cells (vertical
arrows), whereas only a weakly stained basolateral smooth line was observed in C3-injected cells (vertical arrowhead). The position of Z
section is indicated by a horizontal arrow. Scale bar 5 11.25 mm.
fibers was specifically inhibited by antisense EDG-3 gel, which is known to promote the morphogenesis on
PTO. These data support the notion that induction of HUVEC into capillary-like networks (Passaniti et al.,
Rac pathway by EDG-1 and Rho pathway by EDG-3 1992). As shown in Figure 5, SPP, in a dose-dependent
are necessary for the SPP-induced adherens junction manner, promoted HUVEC morphogenesis, whereas
assembly. other lipid analogs ceramide-1-phosphate and sphingo-
myelin were inactive. The maximal effects achieved by 1
mM SPP were indistinguishable from the positive controlSPP-Induced Morphogenesis of Endothelial Cells:
medium which contained FBS. Also, SPP, ranging fromRequirement for Gi-Dependent Cell Survival
100 nM to 1 mM, induced morphogenesis of bovine mi-and Rho/Rac-Dependent Adherens
crovascular endothelial cells (data not shown).Junction Assembly
Inactivation of the heterotrimeric Gi protein by pertus-We next investigated the effect of SPP on morphoge-
netic differentiation of endothelial cells. We used matri- sis toxin inhibited the SPP-induced morphogenesis sug-
Sphingosine-1-Phosphate as an Angiogenic Modulator
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Figure 4. EDG-1 and EDG-3 Mediate SPP-Induced Cytoskeletal Reorganization and Adherens Junction Assembly
(A) Characterization of the efficacy and specificity of EDG-1 and EDG-3 PTOs. Xenopus oocytes were injected with in vitro transcribed RNA
and indicated PTO, and Ca21 rises induced by SPP were performed as described. n 5 number of oocytes injected.
(B) EDG-1 and EDG-3 expression is required for SPP-induced adherens junction assembly. HUVEC were microinjected with antisense (as) or
sense (s) PTO (20 mM in the micropipette) for EDG-1 and EDG-3 as described. Eighteen to twenty-four hours thereafter, cells were stimulated
with 0.5 mM SPP for 1 hr, fixed, and VE-cadherin localization was determined by immunofluorescence microscopy. FITC-IgG column indicates
the microinjected cells, and VE-Cad panels indicate the signal for VE-cadherin in the same microscopic field. Scale bar 5 16 mm.
(C) EDG-1 and EDG-3 regulation of SPP-induced cytoskeletal dynamics. HUVEC were microinjected with EDG-1 and -3 PTO and actin
cytoskeleton was labeled with TRITC-phalloidin as described. Microinjected cells are marked with the FITC-IgG (left column). Note that the
EDG-1 antisense PTO specifically inhibited cortical actin (arrows indicate injected cells; arrowheads, uninjected cells) whereas the EDG-3
PTO blocked stress fiber formation (asterisks indicate injected cells). Scale bar 5 17 mm.
gesting that a Gi-dependent SPP signaling pathway is inhibited in the presence of pertussis toxin and PD98059
(Figure 5F). Also, antisense EDG-1 PTO treatment re-essential (Figure 5B). It is known that a critical function of
angiogenic factors is to promote endothelial cell survival duced the ability of SPP to block ceramide-induced
apoptosis (44% 6 4%) whereas sense EDG-1 PTO or(Ilan et al., 1998; Satake et al., 1998). Indeed, SPP, in a
dose-dependent manner (10±500 nM), significantly pro- antisense EDG-3 or EDG-5 PTO did not have significant
effects (,5%). These data strongly suggest that EDG-tected cells from apoptosis induced by C2-ceramide
(Figures 5E and 5F). This effect was also seen when 1/Gi/ERK pathway mediates SPP-induced endothelial
cell survival.growth factor withdrawal and 15-deoxy-D12,14 prosta-
glandin J2 were used as apoptotic stimuli (data not The Rho inhibitor C3 exoenzyme abolished SPP-
induced morphogenesis of endothelial cells (Figure 5B).shown). This cytoprotective effect of SPP is completely
Cell
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Table 1. SPP-Mediated Cytoskeletal Changes and Adherens Junction Assembly Requires EDG-1 and EDG-3 Expression
Cortical Actin Stress Fiber VE-Cadherin
Treatments (% of cells inhibited) (% of cells inhibited) (% of cells inhibited)
aSEDG-1 (40 mM) 79 6 12 (n 5 90)* 36 6 15 (n 5 90) 89 6 9 (n 5 120)*
aSEDG-1 (20 mM) 64 6 7 (n 5 90)* 17 6 8 (n 5 90) 72 6 11 (n 5 200)*
aSEDG-1 (10 mM) ND 11 6 10 (n 5 40) 67 6 14 (n 5 70)*
SEDG-1 (40 mM) 25 6 7 (n 5 70) 21 6 13 (n 5 70) 21 6 11 (n 5 90)
SEDG-1 (20 mM) ND 13 6 6 (n 5 30) 16 6 13 (n 5 70)
SCEDG-1 (20 mM) 13 6 6 (n 5 200) 14 6 5 (n 5 200) 9 6 7 (n 5 260)
aSEDG-3 (20 mM) 4 6 2 (n 5 40) 66 6 9 (n 5 40)* 53 6 10 (n 5 170)*
SEDG-3 (20 mM) 8 6 6 (n 5 140) 12 6 8 (n 5 140) 8 6 5 (n 5 150)
aSEDG-5 (20 mM) 12 6 7 (n 5 230) 13 6 8 (n 5 230) 10 6 7 (n 5 160)
FITC-IgG 12 6 8 (n 5 220) 11 6 9 (n 5 210) 9 6 8 (n 5 210)
HUVEC cells were injected with indicated PTO. as 5 antisense, s 5 sense, sc 5 scrambled. The concentration of PTO in the micropipette is
indicated in the parentheses. 16±24 hr later, cells were stimulated with SPP (500 nM), fixed, and stained for VE-cadherin and actin. (*) indicates
statistical significance (p , 0.01, t test) of PTOs treatment versus control (FITC-IgG alone). n 5 numbers of cells scored. ND, not determined.
We therefore examined the functional relationship be- Discussion
tween SPP-induced adherens junction assembly and
HUVEC express EDG-1 abundantly and EDG-3 at lowendothelial cell morphogenesis. As shown in Figure
levels. Previous studies have shown that EDG-1 binds5C, the anti-VE-cadherin blocking monoclonal antibody
to the heterotrimeric Gi protein and induces ERK activity(Bach et al., 1998) inhibited SPP-induced morphogene-
(Lee et al., 1996). However, EDG-1 is not capable ofsis dose-dependently. Moreover, as shown in Figure
inducing Gq-dependent responses whereas EDG-3 is5D, EDG-1 and EDG-3 antisense PTO attenuated SPP-
efficiently coupled to Gq and G13 (Ancellin and Hla, 1999;induced HUVEC morphogenesis. Coadministration of
Windh et al., 1999). Indeed, nanomolar concentrationsboth PTOs reduced morphogenesis in an additive man-
of extracellular SPP induced intracellular calcium risesner. In contrast, similar doses of EDG-1, -3 scrambled
as well as ERK activation, and the majority of thoseor sense sequences or the EDG-5 antisense PTO failed
effects are inhibited by pertussis toxin, a specific inhibi-to block the SPP-induced endothelial cell morphogene-
tor of the Gi pathway. It is well established that bothsis (Figure 5D).
intracellular calcium rises and ERK activation can beThese data indicate that SPP activation of endothelial
induced by both Gi as well as Gq pathways (Exton, 1997).cells stimulates two distinct signaling pathways regu-
These data suggest that the majority of calcium changeslated by EDG-1 and -3 receptors: namely, EDG-1/Gi-
and ERK activation are mediated by the Gi-coupled SPPmediated endothelial cell survival and Rho-/Rac-medi-
receptor EDG-1.ated VE-cadherin assembly into adherens junctions.
Bioactive lipids such as SPP and LPA regulate cy-Rho appears to be induced by EDG-3 and Rac by EDG-1
toskeletal architecture by signaling through the Rhosignaling. Both of these receptor-regulated signaling
family of GTPases (Ridley et al., 1992; Nobes and Hall,pathways are important for endothelial cell morphogen-
1995; Postma et al., 1996; Hall, 1998). We show that inesis into capillary-like networks. This is schematically
endothelial cells SPP acts as an extracellular mediatorrepresented in Figure 7.
to induce actin stress fibers and cortical actin. Induction
of stress fibers required the activity of Rho whereasEffects of SPP on Growth Factor±Induced
dominant-negative Rac inhibited both stress fibers andAngiogenesis In Vivo
cortical actin assembly. As expected, SPP effects on
To determine if SPP regulates angiogenesis in vivo, we
the cytoskeleton are not inhibited by pertussis toxin.
utilized the matrigel implant model of subcutaneous an-
These data suggest that SPP interaction with HUVEC
giogenesis in athymic mice (Passaniti et al., 1992). As regulates Rho and Rac activity by a Gi-independentshown in Figure 6, SPP dramatically enhanced FGF- pathway. The question raised by these studies is
2-induced angiogenesis; vascular density and the ap- whether Rho and Rac effects are mediated by EDG-1
pearance of mature vascular structures were greatly or EDG-3 or both.
increased by SPP (Figures 6A and 6B). Supplementation Significantly, SPP treatment of HUVEC regulates the
of FGF-2 with sphingosine did not potentiate angiogen- translocation of Tiam1 (an upstream activator of Rac)
esis. Interestingly, SPP also potentiated VEGF-induced and Rac to cell±cell junctions. Furthermore, VE-cadherin
angiogenesis and antisense PTO of EDG-1 and EDG-3 and catenin molecules are also translocated to discon-
attenuated the formation of mature neovessels in vivo tinuous structures at cell±cell junctions in response to
(Figure 6C). Transmission EM analysis indicated that SPP. Moreover, VE-cadherin partitions into a detergent-
neovessels with well-developed adherens junctions insoluble fraction after SPP treatment, suggesting that
were increased by the FGF-2 and SPP treatment (Figure SPP induces adherens junction assembly in HUVEC.
6D). In addition, SPP treatment induced neovessel matu- Indeed, immunoprecipitation experiments suggest that
ration, as evident by the appearance of basement mem- detergent insoluble b- and g-catenin are found associ-
brane-like structures. These data provide an in vivo cor- ated with other adherens junction proteins and VE-cad-
relate of our in vitro findings that SPP signaling via the herin after SPP treatment. These data indicate that the
EDG-1 and EDG-3 receptors induce morphogenetic dif- adherens junctions in endothelial cells are under dy-
namic control by SPP signaling. In contrast, polypeptideferentiation of endothelial cells.
Sphingosine-1-Phosphate as an Angiogenic Modulator
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Figure 5. EDG-1 and EDG-3 Mediate SPP-Induced Morphogenesis and Survival of Cultured Endothelial Cells
Morphogenesis on matrigel (A) and quantitative analysis of tubular length (B±D) were done as described. Scale bar 5 52 mm. SPP concentrations
are indicated in parenthesis (in mM). SPP1PTx, HUVEC were pretreated with pertussis toxin (PTx, 200 ng/ml) for 2 hr, trypsinized, plated onto
matrigel, stimulated with 500 nM SPP in the presence of PTx (20 ng/ml). SPP 1 C3, HUVEC cells were pretreated with C3 exoenzyme (10 mg/
ml) for 48 hr, trypsinized, plated onto matrigel, stimulated with 500 nM SPP together with same concentration of C3 exotoxin. SPM, sphingomyelin
(1 mM); C1P, C8-ceramide-1-phosphate (1 mM). (C) VE-cadherin is required for SPP-induced morphogenesis. Cultured HUVEC were pretreated
with various concentrations of anti-VE-cadherin or irrelevant mouse IgG (mIgG) for 1 hr. Cells were then trypsinized, plated onto matrigel in
the presence of same amounts of corresponding antibodies without or with 500 nM of SPP. (D) EDG-1 and -3 PTO inhibit SPP-induced
morphogenesis. Individual PTO (0.2 mM in upper panel) was delivered into HUVEC by lipofectin reagent as described. Twenty-four hours later,
cells were trypinized, plated onto matrigel in the absense or presence of SPP (500nM) and tubular length was quantitated. (E) HUVEC were
treated with C2-ceramide in the absence (C2-Cer) or presence (C2-Cer 1 SPP) of 500 nM SPP. The apoptotic nuclei (arrows) were identified
by staining with the Hoechst dye. Scale bar 5 31 mm. (F) HUVEC survival promotion by SPP is dependent on the Gi/MAP kinase pathway.
Cells were incubated with [methyl-3H]-thymidine for 24 hr to label DNA, and then washed before exposure to C2-ceramide in the presence or
absence of SPP for 12 hr. SPP1PTx and SPP1PD98059: cells were pretreated with pertussis toxin (200 ng/ml) and PD98059 (10 mM),
respectively, for 2 hr prior to the addition of C2-ceramide and SPP.
cytokines such as VEGF and TNF-a are known to disrupt pertussis toxin treatment did not inhibit VE-cadherin
and b-catenin translocation, suggesting that a non-Giadherens junctions (Esser et al., 1998; Wojciak-Stothard
et al., 1998), a phenomenon which may be responsible pathway is involved. These data agree with previous
findings in epithelial cells and keratinocytes that ad-for enhanced vascular permeability and increased ex-
travasation of blood-borne cells. Therefore, under physi- herens junction assembly requires the activity of Rho
and Rac (Braga et al., 1997; Takaishi et al., 1997). Thatological conditions in the adult, SPP may promote endo-
thelial cell integrity and functionality. Tiam1 and Rac colocalize with b-catenin after SPP treat-
ment suggests that they may directly participate in theSPP-stimulated translocation of VE-cadherin and
b-catenin to cell±cell junctions requires the activity of linkage of cadherin complexes to the cytoskeleton.
Mechanistic details of how GPCRs regulate Rho andRho and Rac GTPases. Similar to the regulation of actin
cytoskeleton, microinjection of SPP into HUVEC cells Rac activity are not well understood. The G13 and Gq
family of heterotrimeric G proteins have been implicateddid not regulate VE-cadherin and b-catenin transloca-
tion, suggesting that extracellular action of SPP on in Rho activation and stress fiber assembly (Katoh et
al.,1998). Alternatively, a recent study has shown thatplasma membrane receptors is involved. In addition,
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Figure 6. SPP Potentiates FGF-2- and VEGF-Induced Angiogenesis In Vivo
(A) Panels (a) and (b) show the low-power micrograph of angiogenic response in implanted matrigel plugs, whereas (c)±(h) show the histological
analysis of sections of matrigel plugs stained with hematoxylin and eosin. (a) and (d), FGF-2 alone; (b), (f), and (h), SPP 1 FGF-2; (c), vehicle
control; (e), SPP alone; and (g), sphingosine (SPH) 1 FGF. (h) is a high-power view of the boxed area in (f). Note that SPP significantly enhanced
the density and maturation of vascular structures induced by FGF-2 (arrows). Scale bars in (b), (g), and (h) are 320, 40, and 12.8 mm, respectively.
Arrowheads in (A) indicate the border of the matrigel plug.
(B) Quantification of neovessels. Angiogenesis in the fixed matrigel plugs was quantitated by direct counting of vascular structures as described.
Data (mean 6 SD, n 5 4) are from a representative experiment that was repeated twice.
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indeed, recent knockout studies of VE-cadherin illus-
trate the critical role of this molecule in endothelial cell
survival and function (Carmeliet et al., 1999).
In addition, SPP protects endothelial cells potently
from apoptosis induced by ceramide, 15d-PGJ2 and
growth factor withdrawal. These treatments are known
to induce caspase-dependent apoptosis (Cuvillier et al.,
1996; Bishop-Bailey and Hla, 1999). SPP was previously
shown to protect monocytic cells from ceramide in-
duced apoptosis, which was interpreted to occur via a
second messenger action (Cuvillier et al., 1996). In this
study, we show that nanomolar concentrations of extra-
cellular SPP prevented endothelial cell apoptosis. This
effect was completely blocked by pertussis toxin and
the MAP kinase kinase inhibitor PD98059, suggesting
that SPP signaling via the Gi pathway is involved. Indeed,
antisense PTO for EDG-1 but not EDG-3 attenuated the
survival function of SPP. These data imply that SPP
may be an important platelet-derived survival factor for
endothelial cells.
SPP induced endothelial cell morphogenesis into cap-
illary-like networks in the matrigel model of in vitro angio-
genesis. This was potently inhibited by VE-cadherin ex-
tracellular domain antibodies, pertussis toxin, and C3
exotoxin. In addition, EDG-1 and EDG-3 antisense PTO
Figure 7. Model of SPP-Induced Morphogenesis in Endothelial Cells attenuated SPP-induced endothelial cell morphogene-
The interaction of Gi with EDG-1 and Gq and G13 with EDG-3 has sis. However, only the EDG-1 antisense PTO attenuated
been described (Ancellin and Hla, 1999; Windh et al., 1999). Both SPP-induced cell survival. These data strongly suggest
Gq and G13 are known to induce Rho (Katoh et al., 1998). In contrast, that the EDG-3 and -1-mediated adherens junction as-
the heterotrimeric G protein responsible for Rac activation is not
sembly and the protection of endothelial cell survivalknown. Receptor expression inhibition studies with PTO for EDG-1
are required in a coordinated manner during endothelialand -3 indicate that EDG-1 is required for Rac-coupled cortical
cell morphogenesis. That EDG-3 antisense PTO aloneactin assembly and EDG-3 is required for Rho-coupled stress fiber
formation. Both EDG-1 and EDG-3 are required for adherens junc- suppressed SPP-induced morphogenesis strongly sug-
tion assembly and endothelial cell morphogenesis, a critical step of gests that adherens junction assembly is a critical com-
angiogenesis. ponent of morphogenesis. Endothelial cell morphogene-
sis is a complex process that requires cell±extracellular
matrix interactions, directed migration, cell±cell inter-
certain GPCRs may directly bind and activate Rho via actions, perivascular proteolysis, and vessel pruning/
the NPxxY motif (Mitchell et al., 1998). remodeling, which involves apoptosis. Indeed, inhibition
An important question is the requirement for EDG-1 of critical cell±matrix interaction molecules such as avb3
and/or EDG-3 in Rho- and Rac-dependent cytoskeletal with antibodies results in endothelial cell apoptosis and
changes and adherens junction assembly. Using spe- vessel regression (Friedlander et al., 1995; Bader et al.,
cific antisense PTOs against EDG-1 and EDG-3, we pro- 1998). Other studies have also implicated the impor-
vide evidence that both receptors are required; namely tance of VE-cadherin in endothelial cell morphogenesis
that EDG-1 regulates Rac-coupled cortical actin forma- and apoptosis (Bach et al., 1998; Carmeliet et al., 1999).
tion and EDG-3 regulates Rho-coupled stress fiber for- Our data suggest a novel concept that adherens junction
mation. Disruption of either pathway by receptor-spe- assembly is under dynamic control by SPP signaling via
cific antisense PTO or small GTPase inhibitors (C3 EDG-1 and EDG-3 and is required for endothelial cell
exotoxin and dominant-negative Rac) blocked the SPP- morphogenesis and survival. This is schematized in Fig-
induced adherens junction assembly. The proposed ure 7.
model of SPP signaling in endothelial cells is shown in Implantation of SPP- and FGF-2-containing matrigel
Figure 7. These data provide novel evidence for the plugs into athymic mice resulted in significant po-
intricate regulation of VE-cadherin function by the extra- tentiation of FGF-2-induced angiogenesis. Neovessels
cellular SPP receptors EDG-1 and EDG-3. The dynamic formed in the presence of SPP are functionally mature
regulation of VE-cadherin function may be critical for and contain well-developed adherens junctions and base-
ment membranes. However, SPP alone did not inducevascular system development as well as in the adult;
(C) Effect of EDG-1 and EDG-3 PTO and VEGF on SPP-induced angiogenesis. aSEDG, antisense EDG-1 (19.2 mM) 1 antisense EDG-3 (4.8
mM); SEDG, sense EDG-1 (19.2 mM) 1 sense EDG-3 (4.8 mM). FGF, 1.3 mg/ml; SPP, 500 nM; VEGF, 1.4 mg/ml. (*), FGF 1 SPP 1 antisense
versus FGF 1 SPP (p , 0.05, t test); (**), VEGF 1 SPP versus VEGF (p , 0.05, t test).
(D) Transmission electron micrographs of SPP-induced neovessels. (a) vehicle; (b) FGF-2; (c) FGF-2 1 SPP. Inset shows the higher magnification
view of adherens junctional structure between two endothelial cells (arrow in [c]). Arrowheads denote the basement membrane of neovessels
(BV) induced by SPP. Nu, nuclei. Scale bars 5 5 mm in (a)±(c), and 0.5 mm in the inset.
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Tiam1 (1 mg/ml, Santa Cruz), Rac (1 mg/ml, Santa Cruz), Rho (0.4significant angiogenesis. Thus, mechanistically, SPP
mg/ml, Santa Cruz). The primary antibody staining was visualizedlikely acts distinctly albeit cooperatively with VEGF, a
with FITC conjugated goat anti-rabbit or TRITC conjugated sheeppotent and specific inducer of endothelial cell perme-
anti-mouse (1: 1000, Cappel) IgG. Actin microfilaments were stained
ability, survival, and migration (Leung et al., 1989). Ves- with either FTIC- or TRITC-Phalloidin (0.05 mg/ml, Sigma) for 30 min
sels formed in the presence of VEGF are leaky and are at room temperature. Confocal microscopy analysis was carried out
as previously described (Liu et al., 1999).not functional optimally (Iruela-Arispe and Dvorak,
1997). Indeed, SPP also potentiated VEGF-induced an-
VE-Cadherin Analysisgiogenesis. These data suggest that SPP may be a mod-
HUVEC cells were fractionated with cytoskeleton stabilizing bufferulator of angiogenesis which regulates cell±cell junction
(10 mM HEPES [pH 7.4], 250 mM sucrose, 150 mM KCl, 1 mM EGTA,assembly, morphogenesis, cell survival, and vessel mat-
3 mM MgCl2, 13 protease inhibitor cocktail (Calbiochem), 1 mM
uration. Endogenous production of SPP by thrombotic Na3VO4) containing various concentrations of Triton X-100 for 10
platelets and signaling via the EDG-1 pathway may be min at 48C (Hinck et al., 1994). Following centrifugation (15,000 3
g, 15 min), the detergent-soluble and -insoluble fractions were sepa-an important aspect of the angiogenesis process.
rated. The detergent-insoluble fractions were extracted with 1%Data in this report also imply that activation of the
Triton±1% SDS in cytoskeleton stabilizing buffer at 958C for 10 min.EDG-1 and EDG-3 pathways by SPP agonists may be
To detect protein complexes in detergent-insoluble fractions, HUVECuseful in maximally inducing therapeutic angiogenesis,
cells were labeled to steady state with [35S]-methionine (250 mCi/ml,
such as in diabetic wound healing, myocardial angio- NEN DuPont) for 24 hr. After stimulation with 500 nM of SPP for 1 hr,
genesis after ischemic injury, among others. In addition, cells were fractionated with 0.5% Triton X-100. After centrifugation
(15,000 3 g, 15 min), protein complexes in detergent-insoluble frac-combination therapy of SPP-supplemented polypeptide
tions were cross-linked with 0.5 mM DSP (dithiobis[succinimidylangiogenic factors may be useful in the induction of
propionate], Pierce) (Hinck et al., 1994), and extracted with 1% Tritonmature neovessels in vivo. Conversely, inhibition of this
X-100±1% SDS as described. Cell extracts were then immunopre-pathway by EDG-1 and EDG-3 antagonists may be use-
cipitated with anti-VE-cadherin, anti-b-catenin, anti-g-catenin, or
ful in the inhibition of exaggerated angiogenesis that anti-p120 Src substrate (p120cas, Transduction). The immunoprecipi-
occurs in various diseases such as solid tumor growth, tated complexes were then released by incubating in sample buffer
(20% b-mercaptoethanol) at 958C for 10 min and addition of 10 mlrheumatoid arthritis, and diabetic retinopathy.
of 1 M DTT to the gel lanes before protein separation in SDS-PAGE.
Experimental Procedures
Microinjection
HUVEC cells were grown on fibronectin-coated glass bottom dishesCell Culture
for 3 days and microinjected using an Eppendorf MicromanipulatorHUVEC (Clonetics, Cc-2517, p 4±12) were cultured in M199 medium
5171 and Transjector 5246. Approximately 500±800 cells were mi-(Mediatech) supplemented with 10% fetal bovine serum (FBS,
croinjected cytoplasmically with C3 exoenzyme (0.1 mg/ml, Calbio-Hyclone) and heparin-stabilized endothelial cell growth factor, as
chem) or dominant-negative N17Rac protein (0.35 mg/ml; Ridley etpreviously described (Hla and Maciag, 1990). Human embryonic
al., 1992) with Femtotips (Eppendorf) at 100 hPa/0.2 s. Injected cellskidney 293 cells (HEK293, ATCC CRL-1573) were cultured in DMEM
were marked by coinjecting FITC-rabbit IgG (5 mg/ml, Cappel).containing 10% FBS.
Apoptosis AssayMorphogenesis Assay on Matrigel
HUVEC were treated with 1 mM of C2-ceramide (Biomol) for 12 hrMorphogenesis on matrigel was performed as described (Passaniti
in the presence or absence of SPP. Cells were then fixed with metha-et al., 1992). Briefly, HUVEC were trypsinized, resuspended in plain
nol, stained with Hoechst dye (Sigma, 0.5 mg/ml for 5 min). ForM199 medium containing soybean trypsin inhibitor (1 mg/ml, Sigma),
quantitation, HUVEC cells were labeled with [methyl-3H]-thymidinecentrifuged (250 g 3 5 min), resuspended in plain M199 supple-
(5 mCi/ml, NEN DuPont) for 24 hr. Apoptitic DNA was solubilizedmented with 2% charcoal-stripped FBS (CFBS) at a density of 1.5 3
and quantified as described (Cuvillier et al., 1996).105 cells/ml, and cell suspension (200 ml) was seeded in the presence
or absence of SPP (Biomol). Twelve to eighteen hours later, total
tubular length was quantitated by image analysis (Gamble et al., Angiogenesis In Vivo
1993). Female athymic mice (4±6 weeks old) were injected subcutaneously
with 0.4 ml matrigel (approximate protein concentration 9.9 mg/ml,
Collaborative Research) premixed with vehicle (fatty acid free BSA,Poly(A)1 RNA Blot Analysis
Two micrograms of HUVEC and HEK293 poly(A)1 RNA and 280 pg 116 mg/ml, Sigma), FGF-2 (1.3 mg/ml), VEGF (1.4 mg/ml), EDG-1 s/as
PTO (19.2 mM), or EDG-3 s/as PTO (4.8 mM) in the absence orof the EDG-1, EDG-3, EDG-5 in vitro transcripts were loaded and
Northern analysis was conducted as described previously (Hla and presence of various concentrations of SPP. Seven days later, matri-
gel plugs were harvested along with underlying skin and the grossMaciag, 1990).
angiogenic response was recorded under a Zeiss Stemi SV6 dis-
secting microscope (Passaniti et al., 1992). For quantitation, matrigelCalcium Measurements
plugs were fixed with 4% paraformaldehyde in PBS, dehydrated inCells were loaded with Indo-1 acetoxymethyl ester (Indo-1/AM, 5
ethanol and xylene, embedded in paraffin, and sections subjectedmg/ml; Molecular Probes), for 30 min at 378C. Intracellular calcium
to hematoxylin and eosin staining. Angiogenesis was quantitatedchanges were quantitated as described previously (Volpi and Berlin,
by direct counting of vessels containing red blood cells residing1988).
in the stroma interface and the matrigel implant. Each treatment
contains 4±5 mice and two random sections from each were quanti-Immunofluorescence Analysis
fied. Transmission electron microscopy of 2.5% glutaraldehyde-Cells were plated at 2 3 105 cells in 35 mm glass bottom petri dishes.
fixed matrigel plugs was performed as described (Lee et al., 1998).Two days later, cells were washed and changed to medium M199
supplemented with 10% dialyzed CFBS and growth factors for 16
hr. Subsequently, cells were treated with SPP. After treatment, cells Phosphothioate Oligonucleotide Treatment
The following 18-mer phosphothioate oligonucleotides (PTO) werewere washed with ice-cold PBS, fixed, and immunofluorescence
analysis with various antibodies was conducted as follows: VE- synthesized to block the expression of EDG-1 and EDG-3 receptors:
antisense EDG-1, 59-GAC GCT GGT GGG CCC CAT-39 and 59-GCTcadherin (1.25 mg/ml, Transduction Labs; 1 mg/ml Santa Cruz),
b-catenin (1.25 mg/ml, Transduction Labs), g-catenin (1.25 mg/ml, GGT GGG CCC CAT GGT-39; sense EDG-1, 59-ATG GGG CCC ACC
AGC GTC-39; scrambled EDG-1, 59-TGA TCC TTG GCG GGG CCG-39;Transduction Labs), a-catenin (1.25 mg/ml, Transduction Labs),
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antisense EDG-3, 59-CGG GAG GGC AGT TGC CAT-39; sense of the VE-cadherin gene in mice impairs VEGF-mediated endothelial
survival and angiogenesis. Cell 98, 147±157.EDG-3, 59-ATG GCA ACT GCC CTC CCG-39; scrambled EDG-3,
59-ATC CGT CAA GCG GGG GTG-39; antisense EDG-5, 59-CGA, GTA Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P.G., Coso, O.A., Gut-
CAA GCT GCC CAT-39. For the antisense EDG-1 PTO, two related kind, S., and Spiegel, S. (1996). Suppression of ceramide-mediated
sequences whose start points differ by 3 bases were used. Both programmed cell death by sphingosine-1-phosphate. Nature 381,
sequences exhibited similar inhibition of EDG-1 expression and bio- 800±803.
logical effects in HUVEC. The specificity and efficacy of the PTOs Eliceiri, B.P., and Cheresh, D.A. (1999). The role of alpha v integrins
were tested in Xenopus oocytes programmed to express EDG-1 during angiogenesis: insights into potential mechanisms of action
and -3 receptors (Ancellin and Hla, 1999). Briefly, oocytes were and clinical development. J Clin. Invest. 103, 1227±1230.
injected with 20 nl of capped messenger RNA (EDG-1 1 Gqi chimeric
Esser, S., Lampugnani, M.G., Corada, M., Dejana, E., and Risau,G protein, 1 mg/ml of each; EDG-3, 50 ng/ml) premixed with the
W. (1998). Vascular endothelial growth factor induces VE-cadherinindicated PTO (100 ng/ml in water). Thirty-two hours after injection,
tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111, 1853±oocytes were injected with photoprotein Aequorin (20 nl of 1 mg/
1865.ml) and stimulated with 20 nM of SPP. Light emission was recorded
Exton, J.H. (1997). Cell signaling through guanine-nucleotide-bind-for 90 s with a luminometer (Turner Design). Each experiment was
ing regulatory proteins (G proteins) and phospholipases. Eur. J.repeated at least three times with multiple oocytes from different
Biochem. 243, 10±20.frogs. To examine the effects on HUVEC, PTOs and FITC-IgG were
microinjected into the cytoplasm of HUVEC cells using the Eppen- Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid
dorf Transjector microinjector system as described (Macrez-Lepre- and other disease. Nat. Med. 1, 27±31.
tre et al., 1997). Alternatively, PTOs were delivered into HUVEC by Folkman, J., and Haudenschild, C. (1980). Angiogenesis in vitro.
Lipofectin reagent (Life Technologies, Inc.), essentially as described Nature 288, 551±556.
(Ackermann et al., 1999).
Friedlander, M., Brooks, P.C., Shaffer, R.W., Kincaid, C.M., Varner,
J.A., and Cheresh, D.A. (1995). Definition of two angiogenic path-
Supplemental Data ways by distinct alpha v integrins. Science 270, 1500±1502.
For additional data dealing with actin cytoskeletal changes,
Friesel, R.E., and Maciag, T. (1995). Molecular mechanisms of angio-
b-catenin translocation, intracellular microinjection of SPP, and per-
genesis: fibroblast growth factor signal transduction. FASEB J. 9,
tussis toxin effects, which could not be presented here due to space
919±925.
limitations, see http://www.cell.com/cgi/content/full/99/3/301/
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